Saturday 17 October 2026
Export GNTA’s income statement to Excel — free account
Genenta Science S.p.A. Unsponsored ADR
GNTA Healthcare Biotechnology
0.68
0.01
+1.49%
Follow GNTA
| Older periods | Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|---|
Current Ratio |
+7 more quarters Free account |
9.31 | 6.89 | 13.20 | 14.16 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 35.05% | 23.84% | |
Debt/Equity |
0.00 | 0.00 | 0.62 | 0.35 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.08) | (0.10) | (0.55) | (0.27) | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
— | — | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(2.22) | (6.76) | (6.27) | (7.78) | |
Working Capital |
17.85 | 13.39 | 22.03 | 31.52 | |
Capital Expenditures |
0.00 | 0.00 | (0.01) | (0.01) | |
Net Current Asset Value |
17.63 | 13.14 | 13.12 | 22.55 | |
| Other line items | |||||
Quick Ratio |
8.47 | 6.03 | 11.10 | 13.29 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.60 | 0.90 | 0.83 | 1.28 | |
Average Assets |
30.61 | 25.64 | 26.80 | 30.13 | |
Average Common Equity |
28.74 | 23.16 | 20.40 | 23.41 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates